Chemoinformaics analysis of 9-HYDROXY-4-METHOXYFURO[3,2-G]CHROMEN-7-ONE
| Molecular Weight | 232.191 | nRot | 1 |
| Heavy Atom Molecular Weight | 224.127 | nRig | 16 |
| Exact Molecular Weight | 232.037 | nRing | 3 |
| Solubility: LogS | -3.214 | nHRing | 2 |
| Solubility: LogP | 1.918 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 13 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 15 |
| nHA | 5 | APOL | 29.3843 |
| nHD | 1 | BPOL | 14.1017 |
| QED | 0.651 |
| Synth | 2.686 |
| Natural Product Likeliness | 1.565 |
| NR-PPAR-gamma | 0.875 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.004 |
| HIA | 0.02 |
| CACO-2 | -4.872 |
| MDCK | 0.0000257 |
| BBB | 0.016 |
| PPB | 0.82208 |
| VDSS | 0.813 |
| FU | 0.153437 |
| CYP1A2-inh | 0.977 |
| CYP1A2-sub | 0.886 |
| CYP2c19-inh | 0.198 |
| CYP2c19-sub | 0.093 |
| CYP2c9-inh | 0.529 |
| CYP2c9-sub | 0.674 |
| CYP2d6-inh | 0.774 |
| CYP2d6-sub | 0.441 |
| CYP3a4-inh | 0.507 |
| CYP3a4-sub | 0.165 |
| CL | 13.542 |
| T12 | 0.779 |
| hERG | 0.013 |
| Ames | 0.171 |
| ROA | 0.911 |
| SkinSen | 0.524 |
| Carcinogencity | 0.85 |
| EI | 0.21 |
| Respiratory | 0.787 |
| NR-Aromatase | 0.738 |
| Antiviral | No |
| Prediction | 0.570988 |